Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants.

× No keyword cloud information.

26 in total

1. Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis.

Authors: Christel Renoux; Lisa M Lix; Valérie Patenaude; Lauren C Bresee; J Michael Paterson; Jean-Philippe Lafrance; Hala Tamim; Salaheddin M Mahmud; Mhd Wasem Alsabbagh; Brenda Hemmelgarn; Colin R Dormuth; Pierre Ernst
Journal: Clin J Am Soc Nephrol Date: 2015-07-31 Impact factor: 8.237

2. Role of Serotonin Transporter in Antidepressant-Induced Diabetes Mellitus: A Pharmacoepidemiological-Pharmacodynamic Study in VigiBase^®.

Authors: Thi Thu Ha Nguyen; Anne Roussin; Vanessa Rousseau; Jean-Louis Montastruc; François Montastruc
Journal: Drug Saf Date: 2018-11 Impact factor: 5.606

3. A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40-120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder.

Authors: Thomas Shiovitz; William M Greenberg; Changzheng Chen; Giovanna Forero; Carl P Gommoll
Journal: Innov Clin Neurosci Date: 2014-01

4. Antidepressant use and risk of coronary heart disease: meta-analysis of observational studies.

Authors: Seung-Won Oh; Joonseok Kim; Seung-Kwon Myung; Seung-Sik Hwang; Dae-Hyun Yoon
Journal: Br J Clin Pharmacol Date: 2014-10 Impact factor: 4.335

5. Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey.

Authors: Mark Hamer; G David Batty; G David Batty; Adrie Seldenrijk; Mika Kivimaki
Journal: Eur Heart J Date: 2010-11-30 Impact factor: 29.983

6. Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: Phase 2 of a 2-Phase Randomized Clinical Trial.

Authors: Robert J DeRubeis; John Zajecka; Richard C Shelton; Jay D Amsterdam; Jan Fawcett; Colin Xu; Paula R Young; Robert Gallop; Steven D Hollon
Journal: JAMA Psychiatry Date: 2020-03-01 Impact factor: 21.596

7. Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders.

Authors: Valentino Conti; Antonio Lora; Andrea Cipriani; Ida Fortino; Luca Merlino; Corrado Barbui
Journal: Eur J Clin Pharmacol Date: 2012-05-10 Impact factor: 2.953

8. Anti-depressant medication use and C-reactive protein: results from two population-based studies.

Authors: Mark Hamer; G D Batty; Michael G Marmot; Archana Singh-Manoux; Mika Kivimäki
Journal: Brain Behav Immun Date: 2010-09-21 Impact factor: 7.217

9. A 10-year analysis of the effects of media coverage of regulatory warnings on antidepressant use in The Netherlands and UK.

Authors: Juan Francisco Hernandez; Aukje K Mantel-Teeuwisse; Ghislaine J M W van Thiel; Svetlana V Belitser; Jan Warmerdam; Vincent de Valk; Jan A M Raaijmakers; Toine Pieters
Journal: PLoS One Date: 2012-09-20 Impact factor: 3.240

10. Experiences from consumer reports on psychiatric adverse drug reactions with antidepressant medication: a qualitative study of reports to a consumer association.

Authors: Andreas Vilhelmsson; Tommy Svensson; Anna Meeuwisse; Anders Carlsten
Journal: BMC Pharmacol Toxicol Date: 2012-12-23 Impact factor: 2.483